Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients.
(2022)
Journal Article
GUALANO, B., LEMES, Í.R., PIRES DA SILVA, R. et al. 2022. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine and science in sports [online], 32(10), pages 1510-1515. Available from: https://doi.org/10.1111/sms.14213
This prospective cohort study within an open-label, single-arm, phase 4 vaccination trial (clinicaltrials.gov #NCT04754698) aimed to investigate the association between physical activity and persistent anti-SARS-CoV-2 antibodies 6 months after two-do... Read More about Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients..